Morpholino

MO2-cnbpa

ID
ZDB-MRPHLNO-111101-3
Name
MO2-cnbpa
Previous Names
  • MO2-zff9 (1)
  • spl-MO (1)
Target
Sequence
5' - TATCTCTTCTTAGCTTACCCTTTCC - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-cnbpa
Expressed Gene Anatomy Figures
asph Fig. 4 from Armas et al., 2013
cdkn1a Fig. 4 from Armas et al., 2013
cnbpa Fig. 4,  Fig. 6 with image from Armas et al., 2013
col10a1a Fig. 4 from Armas et al., 2013
dlx2a Fig. 6 from Weiner et al., 2011
foxd3 Fig. 3 from Weiner et al., 2011
msx1b Fig. 6 from Weiner et al., 2011
ptk7a Fig. 7 from Margarit et al., 2014
smarca5 Fig. 4 from Armas et al., 2013
sox9b Fig. 4 from Armas et al., 2013
Fig. 3 from Weiner et al., 2011
sox10 Fig. 4 from Armas et al., 2013
Fig. 3 from Weiner et al., 2011
tbx2b Fig. 4,  Fig. 6 with image from Armas et al., 2013
tcf7l2 Fig. 7 from Margarit et al., 2014
tfap2a Fig. 4 from Armas et al., 2013
tp53 Fig. 4 from Armas et al., 2013
wnt5b Fig. 4 from Armas et al., 2013
Phenotype
Phenotype resulting from MO2-cnbpa
Phenotype Fish Figures
anatomical structure cnbpa expression decreased amount, abnormal WT + MO2-cnbpa Fig. 6 with image from Armas et al., 2013
brain apoptotic, abnormal WT + MO2-cnbpa Fig. 4 from Margarit et al., 2014
brain necrotic, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
brain development disrupted, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
cell death increased occurrence, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
ceratobranchial cartilage decreased amount, abnormal WT + MO2-cnbpa Fig. 5 from Margarit et al., 2014
ceratohyal cartilage decreased size, abnormal WT + MO2-cnbpa Fig. 5 from Margarit et al., 2014
ceratohyal cartilage malformed, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
ceratohyal cartilage position, abnormal WT + MO2-cnbpa Fig. 5 from Margarit et al., 2014
chondrocyte morphology, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
chordate embryonic development delayed, abnormal WT + MO2-cnbpa Fig. 4 from Margarit et al., 2014
embryonic viscerocranium morphogenesis process quality, abnormal WT + MO2-cnbpa Fig. 5 from Margarit et al., 2014
ethmoid cartilage morphology, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
eye tbx2b expression decreased amount, abnormal WT + MO2-cnbpa Fig. 6 with image from Armas et al., 2013
eye cnbpa expression decreased amount, abnormal WT + MO2-cnbpa Fig. 6 with image from Armas et al., 2013
eye decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Margarit et al., 2014
Fig. 1 from Weiner et al., 2011
forebrain malformed, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
hindbrain malformed, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
hyosymplectic cartilage decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
immature eye cnbpa expression decreased amount, abnormal WT + MO2-cnbpa Fig. 6 with image from Armas et al., 2013
Meckel's cartilage deformed, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
midbrain malformed, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
midbrain hindbrain boundary aplastic, abnormal WT + MO2-cnbpa Fig. 4 from Margarit et al., 2014
midbrain hindbrain boundary decreased size, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
midbrain hindbrain boundary hypoplastic, abnormal WT + MO2-cnbpa Fig. 4 from Margarit et al., 2014
neurocranium cartilage element decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
optic vesicle tbx2b expression decreased amount, abnormal WT + MO2-cnbpa Fig. 6 with image from Armas et al., 2013
palatoquadrate cartilage decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
pharyngeal arch 1 decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
pharyngeal arch 2 decreased size, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
pharyngeal arch 3-7 disorganized, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
retina malformed, abnormal WT + MO2-cnbpa Fig. 1 from Weiner et al., 2011
splanchnocranium morphology, abnormal WT + MO2-cnbpa Fig. 5 from Margarit et al., 2014
trabecular layer chondrocyte decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Weiner et al., 2011
whole organism tbx2b expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism tp53 expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism cnbpa expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism smarca5 expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism sox9b expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism tfap2a expression decreased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism wnt5b expression increased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
whole organism cdkn1a expression increased amount, abnormal WT + MO2-cnbpa Fig. 4 from Armas et al., 2013
Phenotype of all Fish created by or utilizing MO2-cnbpa
Phenotype Fish Conditions Figures
forebrain malformed, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
ceratohyal cartilage decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 5 from Margarit et al., 2014
pharyngeal arch 2 decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
whole organism cdkn1a expression increased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
whole organism il6 expression decreased amount, abnormal WT + MO2-cnbpa chemical treatment by injection: lipopolysaccharide Fig. 8 with image from Lee et al., 2017
eye cnbpa expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 6 with image from Armas et al., 2013
whole organism tfap2a expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
anatomical structure cnbpa expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 6 with image from Armas et al., 2013
macrophage chemotaxis decreased occurrence, abnormal WT + MO2-cnbpa chemical treatment by injection: lipopolysaccharide Fig. 8 with image from Lee et al., 2017
chondrocyte morphology, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
hyosymplectic cartilage decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
neutrophil chemotaxis decreased occurrence, abnormal WT + MO2-cnbpa bacterial treatment by injection: Shigella flexneri Fig. 8 with image from Lee et al., 2017
trabecular layer chondrocyte decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
embryonic viscerocranium morphogenesis process quality, abnormal WT + MO2-cnbpa standard conditions Fig. 5 from Margarit et al., 2014
chordate embryonic development delayed, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Margarit et al., 2014
whole organism tbx2b expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
optic vesicle tbx2b expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 6 with image from Armas et al., 2013
whole organism wnt5b expression increased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
brain development disrupted, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
neurocranium cartilage element decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
whole organism decreased life span, abnormal WT + MO2-cnbpa bacterial treatment by injection: Shigella flexneri Fig. 8 with image from Lee et al., 2017
Meckel's cartilage deformed, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
brain apoptotic, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Margarit et al., 2014
immature eye cnbpa expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 6 with image from Armas et al., 2013
ceratobranchial cartilage decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 5 from Margarit et al., 2014
whole organism cnbpa expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
retina malformed, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
whole organism smarca5 expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
whole organism tp53 expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
ethmoid cartilage morphology, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
ceratohyal cartilage malformed, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
brain necrotic, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
whole organism sox9b expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Armas et al., 2013
cell death increased occurrence, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
midbrain hindbrain boundary decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
pharyngeal arch 1 decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
eye tbx2b expression decreased amount, abnormal WT + MO2-cnbpa standard conditions Fig. 6 with image from Armas et al., 2013
eye decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Margarit et al., 2014
Fig. 1 from Weiner et al., 2011
splanchnocranium morphology, abnormal WT + MO2-cnbpa standard conditions Fig. 5 from Margarit et al., 2014
ceratohyal cartilage position, abnormal WT + MO2-cnbpa standard conditions Fig. 5 from Margarit et al., 2014
pharyngeal arch 3-7 disorganized, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
midbrain malformed, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
midbrain hindbrain boundary aplastic, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Margarit et al., 2014
midbrain hindbrain boundary hypoplastic, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Margarit et al., 2014
hindbrain malformed, abnormal WT + MO2-cnbpa standard conditions Fig. 1 from Weiner et al., 2011
palatoquadrate cartilage decreased size, abnormal WT + MO2-cnbpa standard conditions Fig. 4 from Weiner et al., 2011
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.